Skip to main content
SpringerLink
Log in
Book cover

Arzneiverordnungs-Report 2006 pp 512–531Cite as

Bronchospasmolytika und Antiasthmatika

  • Chapter

  • 417 Accesses

Auszug

Betasympathomimetika bilden traditionell die größte Arzneimittelgruppe in der Asthmatherapie. Die Domäne der kurzwirkenden Substanzen ist die inhalative Akutbehandlung des Asthmaanfalls. Langwirkende Betasympathomimetika werden jetzt überwiegend in Kombinationspräparaten mit inhalativen Glucocorticoiden verordnet.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Agertoft L, Pedersen. (2000): Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343: 1064–1069.

    Article  PubMed  CAS  Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2006): Arzneiverordnungen. 21.Aufl., Deutscher Ärzte-Verlag, Köln.

    Google Scholar 

  • Barnes PJ, Pauwels RA (1994): Theophylline in the management of asthma: time for reappraisal? Eur Respir J. 7: 579–591.

    Article  PubMed  CAS  Google Scholar 

  • Buhl R, Berdel D, Criée CP et al. (2006): Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. Pneumologie 60: 139–177.

    Article  PubMed  CAS  Google Scholar 

  • Bundesamt für Arzneimittel und Medizinprodukte (BfArM) (1998): Arzneimittel mit problematischer Bioverfügbarkeit. 9. Bekanntmachnung gemäß § 26, Abs. 3 AMG vom 19.1.1998.

    Google Scholar 

  • Chapman KR, Patel P, D’Urzo AD et al. (2005): Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy 60: 330–337.

    Article  PubMed  CAS  Google Scholar 

  • Chung KF, Adcock IM (2004): Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma. Treat Respir Med 3: 279–289.

    Article  PubMed  CAS  Google Scholar 

  • Clarke PS, Ratowsky DA (1990): Effect of fenoterol hydrobromide and sodium cromoglycate individually and in combination on postexercise asthma. Ann Allergy 64(2 Pt. 2): 187–190.

    PubMed  CAS  Google Scholar 

  • Crout JR (1974): Fixed combination prescription drugs: FDA policy. J Clin Pharmacol 14: 249–254.

    PubMed  CAS  Google Scholar 

  • Debelic M, Hertel G, König J (1988): Double-blind crossover study comparing sodium cromoglycate, reproterol, reproterol plus sodium cromoglycate, and placebo in exercise-induced asthma. Ann Allergy 61: 25–29.

    PubMed  CAS  Google Scholar 

  • Ducharme FM, Hicks GC (2001): Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma. The Cochrane Library, Issue 2. Oxford: Update Software.

    Google Scholar 

  • Ducharme FM (2003): Inhaled glucocorticoids versus leukotriene receptor antagonsists as single agent asthma treatment: systematic review of current evidence. Brit Med J 326: 619.

    Article  Google Scholar 

  • Gehrke I, Bohm E, Sybrecht GW (1986): Stress-induced asthma — placebo-controlled double-blind comparison of prevention using fenoterol, disodium cromoglycate and a combination of the two. Prax Klin Pneumol 40: 129–134.

    PubMed  CAS  Google Scholar 

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2003): Pocket guide to COPD Managmenent, Diagnosis, and Prevention. http://www.goldcopd.com/revised_gp.pdf, updated July 2003, aufgerufen 9.5.2004.

    Google Scholar 

  • Grahnén A, Eckernas SA, Brundin RM, Ling-Andersson A (1994): An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 38: 521–525.

    PubMed  Google Scholar 

  • Hanania NA, Chapman KR, Sturtridge WC et al. (1995): Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 96: 571–579.

    Article  PubMed  CAS  Google Scholar 

  • Jarvis B, Markham A (2000): Montelukast — a review of its therapeutic potential in persistent asthma. Drugs 59: 891–928.

    Article  PubMed  CAS  Google Scholar 

  • Keam SJ, Keating GM (2004): Tiotropiumbromid — a review of its use as maintenance therapy in patient with COPD. Treat Respir Med 3: 247–268.

    Article  PubMed  CAS  Google Scholar 

  • Lemmer B (1990): Chronopharmakologische Aspekte der Theophyllintherapie. In: Blume H (Hrsg.): Bioäquivalenz retardierter Theophyllin-Fertigarzneimittel. Govi, Frankfurt, S. 75–82.

    Google Scholar 

  • Lemmer B, Wettengel R (2004): Erkrankungen der Atemwege. In: Lemmer B, Brune K (Hrsg.): Pharmakotherapie — Klinische Pharmakologie. 12. Aufl., Springer Verlag, Berlin Heidelberg New York, S. 347–366.

    Google Scholar 

  • Lipworth BJ (1999): Modern drug treatment of chronic asthma. Brit Med J 318: 380–383.

    PubMed  CAS  Google Scholar 

  • Markham A, Jarvis B (2000): Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Drugs 60: 1207–1233.

    Article  PubMed  CAS  Google Scholar 

  • McCowan C, Neville RG, Thomas GE, Crombie IK, Clark RA et al. (1998): Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland. Brit Med J 316: 668–672.

    PubMed  CAS  Google Scholar 

  • Nannini L, Cates CJ, Lasserson TJ, Poole P (2005): Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews, Issue 2.

    Google Scholar 

  • National Asthma Education and Prevention Program Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics-2002 [EPR-Update 2002] (2002). NIH Publication No. 02-5074, June 2003. http://www.nhlbi.nih.gov/guidelines/asthma/index. htm.

    Google Scholar 

  • N.N. (2005): Leukotriene receptor antagonists — an update. Drug Ther Bull 43: 85–88.

    Article  Google Scholar 

  • Ram FS, Cates CJ, Ducharme FM (2005): Lang-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev, Jan 25.

    Google Scholar 

  • Robinson DS, Campbell D, Barnes PJ (2001): Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet 357: 2007–2011.

    Article  PubMed  CAS  Google Scholar 

  • Rodrigo G, Rodrigo C, Burschtin O (1999): A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 107: 363–370.

    Article  PubMed  CAS  Google Scholar 

  • Schmidt H (1994): Retardtheophyllin ist nicht gleich Retardtheophyllin. Atemwegs-Lungenkr 20: 223–231.

    Google Scholar 

  • Sears MR, Rea HH, Fenwick J et al. (1987): 75 Deaths in asthmatics prescibed home nebulisers. Brit Med J 294: 477–480.

    Article  CAS  Google Scholar 

  • Smolensky MH, D’Alonso GE (1997): Progress in the chronotherapy of nocturnal asthma. In: Redfern P, Lemmer B (eds.): Physiology and Pharmacology of Biological Rhythms. Handbook of Experimental Pharmacology, Vol. 125, Springer, Berlin, Heidelberg, New York, pp. 205–249.

    Google Scholar 

  • Sweetman SC (ed) (2002): Martindale: The complete drug reference. 33nd ed Pharmaceutical Press, London, pp 1082–1102.

    Google Scholar 

  • The Childhood Asthma Management Program Research Group [CAMP 2000] (2000): Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343: 1054–1063.

    Article  Google Scholar 

  • Undem BJ (2006): Pharmacotherapy of asthma. In: Brunton LL, Lazo JS, Parker KL (eds.): Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th ed., McGraw Hill, New York, pp. 717–736.

    Google Scholar 

  • van der Wouden JC, Tasche MJ, Bernsen RM et al. (2003): Inhaled sodium cromoglycate for asthma in children. Cochrane Database Syst. Rev. 2003.

    Google Scholar 

  • von Berg A, Albrecht B, Darlath W, Voß HW, Berdel D (2002): Intraindividuelle, randomisierte Doppelblindstudie zum Vergleich des protektiven Effektes zwischen verschiedenen Anwendungsformen von DNCG und Reproterol bei Kindern mit Anstrengungsasthma. Allergologie 25: 557–564.

    Google Scholar 

  • Weinberger M, Hendeles L (1996): Theophylline in asthma. N Engl J Med 334: 1380–1388.

    Article  PubMed  CAS  Google Scholar 

  • Wilson AM, Lipworth BJ (1999): 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids. Thorax 54: 20–26.

    Article  PubMed  CAS  Google Scholar 

  • Worth H, Buhl R, Cegla U, Criée CP, Gillissen A, Kardos P, Kohler D, Magnussen H, Meister R, Nowak D, Petro W, Rabe KF, Schultze-Werninghaus G, Sitter H, Teschler H, Welte T, Wettengel R; Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie (2002): Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 56: 704–738.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Maybachstraß 14-16, 68169, Mannheim

    Prof. Dr. med. Dr. h.c. Björn Lemmer

Authors
  1. Prof. Dr. med. Dr. h.c. Björn Lemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Lemmer, B. (2007). Bronchospasmolytika und Antiasthmatika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34370-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34370-7_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34369-1

  • Online ISBN: 978-3-540-34370-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation